These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10359414

  • 1. L-dopa slows the progression of familial parkinsonism.
    Gwinn-Hardy K, Evidente VG, Waters C, Muenter MD, Hardy J.
    Lancet; 1999 May 29; 353(9167):1850-1. PubMed ID: 10359414
    [No Abstract] [Full Text] [Related]

  • 2. Parkinson's disease: progression and mortality in the L-DOPA era.
    Di Rocco A, Molinari SP, Kollmeier B, Yahr MD.
    Adv Neurol; 1996 May 29; 69():3-11. PubMed ID: 8615142
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Genetic linkage studies in autosomal dominantly inherited L-DOPA responsive parkinsonism. Evaluation of candidate genes.
    Gasser T, Wszolek Z, Supala A, Trofatter J, Ozelius L, Uitti RJ, Pfeiffer RF, Gusella J, Calne D, Breakefield XO.
    Adv Neurol; 1996 May 29; 69():87-95. PubMed ID: 8615189
    [No Abstract] [Full Text] [Related]

  • 5. Does levodopa therapy delay death in Parkinson's disease?
    Uitti RJ, Ahlskog JE, Maraganore DM.
    Mov Disord; 1996 May 29; 11(3):343-4. PubMed ID: 8723162
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dopa-responsive, nonprogressive juvenile parkinsonism: report of a case.
    Rajput A, Kishore A, Snow B, Bolton CF, Rajput AH.
    Mov Disord; 1997 May 29; 12(3):453-6. PubMed ID: 9159748
    [No Abstract] [Full Text] [Related]

  • 9. [L-dopa and antiparkinson agents].
    Delwaide PJ.
    Rev Med Liege; 1996 Jan 29; 51(1):61-4. PubMed ID: 8701139
    [No Abstract] [Full Text] [Related]

  • 10. Levodopa in the early treatment of Parkinson's disease.
    Murata M.
    Parkinsonism Relat Disord; 2009 Jan 29; 15 Suppl 1():S17-20. PubMed ID: 19131036
    [Abstract] [Full Text] [Related]

  • 11. Hereditary spastic paraplegia associated with dopa-responsive parkinsonism.
    Micheli F, Cersósimo MG, Zúñiga Ramírez C.
    Mov Disord; 2006 May 29; 21(5):716-7. PubMed ID: 16463348
    [Abstract] [Full Text] [Related]

  • 12. SCA2 may present as levodopa-responsive parkinsonism.
    Payami H, Nutt J, Gancher S, Bird T, McNeal MG, Seltzer WK, Hussey J, Lockhart P, Gwinn-Hardy K, Singleton AA, Singleton AB, Hardy J, Farrer M.
    Mov Disord; 2003 Apr 29; 18(4):425-9. PubMed ID: 12671950
    [Abstract] [Full Text] [Related]

  • 13. [Parkinson, what's new? L-Dopa, The Lancet answers].
    Nau JY.
    Rev Med Suisse; 2014 Jun 25; 10(436):1430-1. PubMed ID: 25055483
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
    Pahwa R, Koller WC.
    Adv Neurol; 1996 Jun 25; 69():487-91. PubMed ID: 8615169
    [No Abstract] [Full Text] [Related]

  • 15. Adverse reactions to levodopa: drug toxicity or progression of disease?
    Agid Y, Chase T, Marsden D.
    Lancet; 1998 Mar 21; 351(9106):851-2. PubMed ID: 9525359
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Who dropped the ball on L-DOPA? A patient's lament.
    Palfreman J.
    J Parkinsons Dis; 2014 Mar 21; 4(3):313-6. PubMed ID: 24946968
    [No Abstract] [Full Text] [Related]

  • 18. [Comparative study on Parkopan, Amantadine and L-dopa in the treatment of Parkinson's disease].
    Dzudza M, Dzudza D.
    Med Arh; 1974 Mar 21; 28(4):407-15. PubMed ID: 4613968
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Levodopa-responsive parkinsonism associated with hydrocephalus.
    Kim MJ, Chung SJ, Sung YH, Lee MC, Im JH.
    Mov Disord; 2006 Aug 21; 21(8):1279-81. PubMed ID: 16639728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.